KLK3 and posterior cortical atrophy: Although high-throughput transcriptome profiling techniques have been widely used to identify biomarkers for improving the diagnosis of PCa, patient prognosis and risk stratification are mainly dependent on clinicopathological parameters, including PSA, pathological T stage, and the Gleason score [30].